Answers are grounded in this paper and cite their sources.
This investigation reveals that BMSC-derived exosomal ANTXR1 suppresses erythroid differentiation, indicating a novel regulatory mechanism in aplastic anemia.
Aplastic anemia (AA) is a bone marrow failure syndrome characterized by impaired hematopoiesis and a dysfunctional marrow microenvironment. Bone marrow-derived mesenchymal stem cell (BMSC)-derived exosomes play a crucial role in intercellular communication; however, the role of exosomal anthrax toxin receptor 1 (ANTXR1) in erythroid differentiation remains unclear. Mouse BMSCs were isolated, characterized, and transfected with either ANTXR1-overexpressing or ANTXR1-silencing lentiviral vectors. Exosomes were collected and identified using transmission electron microscopy, nanoparticle tracking analysis, and exosomal marker detection. K562 cells and human cord blood CD34⁺cells were treated with these exosomes. Erythroid differentiation was evaluated through flow cytometry for CD235a and CD71, benzidine staining, RT-qPCR, and Western blot analysis of GATA1 and ALAS2. Apoptosis and inflammatory signaling were examined using flow cytometry, ELISA, Western blotting, and co-immunoprecipitation. TLR4 inhibitor and agonist treatments were applied to verify pathway involvement. BMSC-derived exosomes successfully carried ANTXR1, and their abundance reflected ANTXR1 expression in donor BMSCs. Exosomes enriched in ANTXR1 inhibited erythroid differentiation, as evidenced by reduced CD235a/CD71 expression, decreased GATA1 and ALAS2 levels, and diminished hemoglobin synthesis. In contrast, ANTXR1-deficient exosomes promoted erythroid differentiation and apoptosis while activating the TLR4/MyD88/NF-κB pathway. Pharmacological inhibition of TLR4 attenuated these effects, whereas TLR4 agonist treatment enhanced them. Co-immunoprecipitation further supported an interaction between ANTXR1 and TLR4. BMSC-derived exosomal ANTXR1 suppresses erythroid differentiation, at least in part, by modulating the TLR4/MyD88/NF-κB signaling pathway. These findings identify exosomal ANTXR1 as a potential regulator of erythropoiesis.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: